zacks.com

BRO's third-quarter 2025 results are likely to reflect improved underwriting results, higher average interest rates, and growth in new business.

URI posts record third-quarter revenues and adjusted EBITDA on solid construction demand, but earnings fall short of estimates.

PFG's Q3 results are likely to reflect increased average AUM, higher average invested assets, and favorable market performance.

SAP's Q3 earnings surge 29% as cloud and AI momentum lift revenues and margins, driving a strong 2025 outlook for growth and cash flow.

Novo Nordisk's Q3 results hinge on Ozempic and Wegovy sales as demand growth slows amid rivalry, market limits and compounded drug headwinds.

Halozyme boosts its 2025 revenue outlook on surging royalties from Darzalex SC, Phesgo and Vyvgart Hytrulo, though partner reliance persists.

Surging demand for optical solutions and stronger 2025 growth prospects place Corning ahead of Qualcomm in the tech race.

GL's third-quarter results reflect higher Life and Health insurance premiums, improved insurance underwriting income, and lower expenses.

Amid weak oil prices and investor caution, Canadian Natural Resources, Arc Resources and Baytex Energy stand out for resilience and disciplined execution.

Can BBAI's defense-driven momentum outpace AI's enterprise struggles and restructuring headwinds?